Jazz Pharmaceuticals Posts Refund Notice on HRSA Website

Jazz Pharmaceuticals owes refunds to 340B providers, according to a notice posted on HRSA's website.
Jazz Pharmaceuticals owes refunds to 340B providers, according to a notice posted on the Health Resources and Services Administration’s Office [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Improved Non-Profit Hospital Outlook Helped by 340B Payout: Moody’s

Matt Cahil
The 340B program could have a big impact on not-for-profit hospital finances, said Matt Cahill, assistant vice president for Moody’s.
The 2024 outlook for not-for-profit hospital and health systems improved from negative to stable, in part, due to the planned [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Hospitals Charge Higher Commercial Insurance Prices, Says PhRMA Funded Report

Neil Masia
Neil Masia, Ph.D., authored a Health Capital Group report that found 340B hospitals charge higher commercial insurance prices than non-340B hospitals.
The average hospital in the 340B program charges commercial insurers more than non-340B hospitals, according to a new report, which [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GlaxoSmithKline Posts Refund Notice on HRSA Website

GlaxoSmithKline wordmark and GSK logo on a building
GlaxoSmithKline and Pfizer announced updates to their 340B contract pharmacy policies to comply with new state laws that will take effect in July.
GlaxoSmithKline owes refunds to 340B providers, according to a notice posted on the Health Resources and Services Administration’s Office of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genesis Ruling Could Expand 340B-Eligible Prescriptions, Say Some Attorneys

Kyle Vasquez, an attorney for Polsinelli, said the Genesis ruling was "limited in reach" but could create obstacles for other HRSA enforcement activity.
A recent ruling by a federal district judge in South Carolina potentially could expand 340B-eligible prescriptions, say some provider advisers. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospitals Urge CMS to Reconsider Future Cuts in 340B Lump Sum Final Rule

Tom Kraus, a vice president of the American Society of Health-System Pharmacists, said he was "deeply concerned" with future cuts in CMS' 340B lump sum final rule.
Hospital advocates praised the recent Medicare final rule implementing a $9 billion lump sum payment to 340B hospitals but worried [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Medicare to Continue ASP Plus 6% for 340B Drugs in 2024

CMS
In response to the ongoing Change Healthcare cyberattack, CMS will direct contractors to provide some accelerated payments to hospitals.
Medicare Part B will continue to pay hospitals for 340B drugs at the rate of average sales price (ASP) plus [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

CMS Finalizes 340B Lump Sum Payment, Retains Offsetting Cuts Starting in 2026

CMS headquarters
CMS issued the final rule to implement a $9 billion lump sum payment to 340B hospitals for previous illegal cuts between 2018 and 2021.
Medicare issued a final rule today to implement a $9 billion lump sum payment to 340B hospitals and to cut [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health Systems Sue to Reverse Elimination of Hospital Registration Waiver

U.S. District Court of the District of Columbia
A hospital association asked the U.S. District Court of the District of Columbia to side with more than 40 health systems that sued federal regulators over a hospital registration policy change.
Forty-four health systems and hospitals sued federal healthcare agencies over their recent decision to end a 340B COVID-related registration flexibility [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Lobbying Still on Track for Record Year

Darbin Wofford, a health policy advisor at Third Way, said his organization is urging Congressional Democrats to adopt 340B program reforms.
Lobbying on 340B issues in 2023 remains on track for a record-breaking year, according to recently released congressional lobbying reports. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live